COPSI-Plus

Not Applicable

Conditions: Health Condition 1: F20- Schizophrenia

Registration Number: CTRI/2023/09/057223

Lead Sponsor: ational Institute of Mental Health

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Illness duration of =12 months and an overall moderate severity of the illness based on the Clinical Global Impression- Schizophrenia (CGI-SCH) scale. Eligible patients must also have at least one risk factor for early mortality which commonly occurs among individuals with schizophrenia such as hypertension, diabetes, dyslipidemia, current tobacco use, and/or overweight or obesity.

Exclusion Criteria

Participants who are planning to move out of the study catchment areas in the next 12 months, and those who do not speak either of the primary local languages, Hindi in Madhya Pradesh or Kannada in Karnataka, individuals with a diagnosis of dementia, or evidence of significant cognitive impairment, individuals who have major visual impairment or who cannot operate a smartphone will be excluded.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient-Level Outcome Measures: <br/ ><br>1. Disability <br/ ><br>Implementation-Level Outcome Measures: <br/ ><br>1. Patient engagement in COPSITimepoint: Baseline, 6 and 12 months

Secondary Outcome Measures

Name	Time	Method
Implementation-Level Outcome Measures: <br/ ><br>1. Fidelity of COPSI delivery <br/ ><br>2. Costs of COPSI and mindLAMP vs. COPSI <br/ ><br>Timepoint: Baseline, 6 and 12 months;Patient-Level Outcome Measures: <br/ ><br>1. Mental health: Symptoms, cognition. <br/ ><br>2. Physical health and functional: sleep, QoL, social functioning, cardiovascular risk, health metrics. <br/ ><br>3. Digital dataTimepoint: Baseline, 6 and 12 months